Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Ischemic Vascular Disease: Daily Aspirin or Other Antiplatelet Therapy Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 7 Clinics in the Meriter Health Services health system


The results below represent the care of 431 patients with coronary and other atherosclerotic vascular disease. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
UnityPoint Health Meriter Deforest-Windsor Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
UnityPoint Health Meriter Fitchburg Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
UnityPoint Health Meriter McKee Clinic
N=108
94.44 %
View Historical Data
UnityPoint Health Meriter Middleton Clinic
N=116
96.55 %
View Historical Data
UnityPoint Health Meriter Monona Clinic
N=207
92.27 %
View Historical Data
UnityPoint Health Meriter Stoughton Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
UnityPoint Health Meriter West Washington Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance

There has been important evidence from clinical trials that further supports and broadens the merits of risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease.

Based on trials involving other secondary prevention therapies, the ACC and AHA recommends aspirin in all patients, unless contraindicated, with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. The ACC and AHA also recommend the use of other antiplatelet agents based on disease type and clinical conditions.

This measure shows the percentage of people 18 to 75 years of age with a diagnosis coronary or other atherosclerotic vascular disease who were prescribed oral antiplatelet therapy, unless contraindicated, in the measurement year.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.